Showing results (31-40 of 676) with videos related to
Sort By:
Pageof 68
International Immunopharmacology|February 27, 2016
First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-upA Razzaque Ahmed, Tegan Nguyen, Srini Kaveri, et al.Journal of the American Academy of Dermatology|February 8, 2016
Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-upA Razzaque Ahmed, Shawn Shetty, Srini Kaveri, et al.Acta Neuropathologica Communications|June 3, 2014
Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomographyJanos Groh, David Stadler, Mathias Buttmann, et al.International Journal of Molecular Sciences|August 20, 2015
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial CellsAxel Haarmann, Mathias Nehen, Annika Deiß, et al.Journal of the Neurological Sciences|July 29, 2010
Fluctuating neuromuscular transmission defects and inverse acetazolamide response in episodic ataxia type 2 associated with the novel CaV2.1 single amino acid substitution R2090QNico Melzer, Joseph Classen, Karlheinz Reiners, et al.Expert Review of Neurotherapeutics|March 2, 2013
Treating multiple sclerosis with monoclonal antibodies: a 2013 updateAnnika Deiß, Isabel Brecht, Axel Haarmann, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2012
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosisGesa Weise, Markus Hupp, Andreas Kerstan, et al.Trends in Neurosciences|January 5, 2010
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosisOrhan Aktas, Bernd Kieseier, Hans-Peter HartungJournal of Neurochemistry|April 20, 2007
Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentrationMathias Buttmann, Alexander Lorenz, Andreas Weishaupt, et al.Nature Reviews. Neuroscience|April 2, 2005
Statins--a cure-all for the brain?Til Menge, Hans-Peter Hartung, Olaf StüvePageof 68